10-QPeriod: Q2 FY2005

UNITEDHEALTH GROUP INC Quarterly Report for Q2 Ended Jun 30, 2005

Filed August 8, 2005For Securities:UNH

Summary

UnitedHealth Group Inc. (UNH) filed its 10-Q for the period ending June 29, 2005, highlighting ongoing share repurchase activity and key shareholder meeting outcomes. The company continued to execute its share repurchase program, acquiring nearly 19 million shares during the second quarter at an average price of $48.04. This demonstrates a commitment to returning capital to shareholders. The filing also details the results of the May 3, 2005, Annual Shareholder Meeting, where directors were elected, and the appointment of Deloitte & Touche LLP as the independent auditor was ratified with strong support. Notably, two shareholder proposals related to executive compensation, specifically performance-vesting shares and performance-based options, did not pass. Furthermore, the report discloses significant operational updates, including the partial termination of a technology services agreement with IBM, anticipated to transition in early 2006 and involve a $4.8 million termination fee. Additionally, amendments to the employment agreements of CEO William W. McGuire, M.D., and President & COO Stephen J. Hemsley were approved, introducing changes to compensation structures and terms, including a provision for Dr. McGuire to be retained as a consultant post-retirement. Investors should note the company's proactive capital allocation strategy through share buybacks and the governance decisions made at the annual meeting.

Key Highlights

  • 1UnitedHealth Group repurchased 18,988,400 shares of common stock during the second quarter of 2005, reflecting a significant capital return initiative.
  • 2The average purchase price for shares bought back in Q2 2005 was $48.04, with the company authorized to repurchase up to 130 million shares under its ongoing program.
  • 3The Annual Shareholder Meeting on May 3, 2005, saw the election of four directors and the ratification of Deloitte & Touche LLP as the independent auditor.
  • 4Shareholder proposals concerning performance-vesting shares and performance-based options for executive compensation were not approved.
  • 5The company announced its intention to terminate a portion of its IT services agreement with IBM, expecting the transition to be completed in Q1 2006.
  • 6Employment agreements for CEO William W. McGuire, M.D., and President & COO Stephen J. Hemsley were amended, with changes to compensation and post-employment arrangements.
  • 7A two-for-one stock split was declared and became effective on May 27, 2005, with all prior share and per share amounts restated accordingly.

Frequently Asked Questions

The company actively engaged in share repurchases during the second quarter of 2005, buying back nearly 19 million shares. This indicates a commitment to returning value to shareholders through its authorized repurchase program.

The meeting resulted in the election of four directors, the ratification of Deloitte & Touche LLP as the independent auditor, and the rejection of two shareholder proposals related to executive compensation structures (performance-vesting shares and performance-based options).

Yes, UnitedHealth Group intends to terminate a portion of its technology services agreement with IBM, citing internal capabilities. This transition is expected in the first quarter of 2006 and will incur a $4.8 million termination fee. The remainder of the agreement with IBM will continue.

The employment agreements for CEO William W. McGuire, M.D., and COO Stephen J. Hemsley have been amended. These amendments include adjustments to compensation discretion, future equity grants, and provisions related to severance, consulting arrangements, and retirement scenarios, particularly for Dr. McGuire.